Status:
TERMINATED
Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Tuberculosis
Eligibility:
All Genders
6-5 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to see whether children who take vitamins along with the standard medicine for tuberculosis (TB) recover better and quicker than children who take only the standard medici...
Detailed Description
Tuberculosis (TB) remains the single most common infectious disease cause of mortality worldwide with evidence that support nutritional status may be associated with poor outcomes in TB patients. Data...
Eligibility Criteria
Inclusion
- Loss of more than 10% of maximum weight or failure to gain weight for 2 months.
- Having cough with wheeze for 4 weeks or more.
- History of household contact with a probable or confirmed tuberculosis case in the past 6 months.
- Pyrexia of unknown origin.
- Painless swelling in a group of cervical lymph nodes.
- Children who were diagnosed with TB in the past 5 years and have received anti-tuberculosis therapy for a period less than 4 weeks.
Exclusion
- Children who have been treated with anti-tuberculosis therapy exceeding 4 weeks in the past one year will not be eligible for entry into the study
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00145184
Start Date
May 1 2005
End Date
August 1 2007
Last Update
March 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Muhimbili University, College of Health Sciences
Dar es Salaam, Tanzania